Filing Details

Accession Number:
0001144204-13-066404
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-09 17:44:20
Reporting Period:
2013-12-09
Filing Date:
2013-12-09
Accepted Time:
2013-12-09 17:44:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1518734 George Cardoza C/O Neogenomics, Inc.
12701 Commonwealth Drive Suite 9
Fort Myers FL US 33913
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-09 20,000 $1.55 71,089 No 4 A Direct
Common Stock Disposition 2013-12-09 20,000 $3.66 51,089 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy) Acquisiton 2013-12-09 20,000 $1.55 0 $1.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
130,000 2010-11-30 2014-11-29 No 4 X Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect Trust by Self
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to buy) $1.46 2012-04-14 2016-04-13 0 100,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-04-13 0 100,000 Direct
Footnotes
  1. On November 30, 2009 Mr. Cardoza was granted an option to purchase 150,000 shares. The options were all time based and vest ratable over each of Mr. Cardoza's first four anniversaries with the Company.
  2. On April 14, 2011 Mr. Cardoza was granted an option to purchase 100,000 shares. These options vest ratably at the first four anniversary dates of the grant.